| Document Entity Information - USD ($) | 9 Months Ended | ||
| Dec. 31, 2015 | Mar. 15, 2016 | Jun. 30, 2015 | |
| Document And Entity Information [Abstract] | |||
| Entity Registrant Name | EOS INC. | ||
| Entity Central Index Key | 1,651,958 | ||
| Trading Symbol | eoin | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Filer Category | Smaller Reporting Company | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Common Stock, Shares Outstanding | 64,122,997 | ||
| Entity Public Float | $ 0 | ||
| Document Type | 10-K | ||
| Document Period End Date | Dec. 31, 2015 | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2,015 | ||
| Document Fiscal Period Focus | FY |
| BALANCE SHEETS | Dec. 31, 2015USD ($) |
| Current Assets | |
| Cash and cash equivalents | $ 54,132 |
| Total Current Assets | 54,132 |
| Total Assets | 54,132 |
| Current Liabilities | |
| Due to related parties | 150,000 |
| Total Current Liabilities | 150,000 |
| Total liabilities | 150,000 |
| Stockholders' Equity | |
| Common stock, par value $0.001 per share, 75,000,000 share authorized, 54,122,997 shares issued and outstanding | 54,123 |
| Deficit accumulated during development stage | (149,991) |
| Total Stockholders' Equity | (95,868) |
| Total Liabilities and Equity | $ 54,132 |
| BALANCE SHEETS (Parentheticals) | Dec. 31, 2015$ / sharesshares |
| Statement of Financial Position [Abstract] | |
| Common stock, par value (in dollars per share) | $ / shares | $ 0.001 |
| Common stock, shares authorized | 75,000,000 |
| Common stock shares issued | 54,122,997 |
| Common stock, shares outstanding | 54,122,997 |
| STATEMENTS OF OPERATIONS | 9 Months Ended |
| Dec. 31, 2015USD ($)$ / sharesshares | |
| Income Statement [Abstract] | |
| Revenue | |
| General and administrative expenses | $ 150,000 |
| Loss from operations | (150,000) |
| Loss before income taxes | (150,000) |
| Other income (expenses) | |
| Interest income | 9 |
| Total other income(expenses) | $ 9 |
| Provision for income taxes expense | |
| Net loss | $ (149,991) |
| Weighted average number of common shares: | |
| Basic and diluted (in shares) | shares | 54,122,997 |
| Net loss per share: | |
| Basic and diluted (in dollars per share) | $ / shares | $ 0 |
| STATEMENTS OF CASH FLOWS | 9 Months Ended |
| Dec. 31, 2015USD ($) | |
| Cash flows from operating activities | |
| Net loss | $ (149,991) |
| Cash flows from financing activities | |
| Proceeds from issuance of common stock | 54,123 |
| Loan from officers | 150,000 |
| Net cash provided by financing activities | 204,123 |
| Net increase in cash and cash equivalents | $ 54,132 |
| Cash and cash equivalents | |
| Beginning | |
| Ending | $ 54,132 |
| Cash paid during the period for: | |
| Interest | |
| Income tax |
| STATEMENTS OF SHAREHOLDERS' EQUITY - 9 months ended Dec. 31, 2015 - USD ($) | Common Stock | Deficits Accumulated during the development stage | Total |
| Balance at Apr. 02, 2015 | |||
| Balance (in shares) at Apr. 02, 2015 | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
| Common stock issuance | $ 54,123 | $ 54,123 | |
| Common stock issuance (in shares) | 54,122,997 | ||
| Net loss for the period ended December 31, 2015 | $ (149,991) | (149,991) | |
| Balance at Dec. 31, 2015 | $ 54,123 | $ (149,991) | $ (95,868) |
| Balance (in shares) at Dec. 31, 2015 | 54,122,997 |
| NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES | 9 Months Ended |
| Dec. 31, 2015 | |
| Nature Of Operations And Summary Of Accounting Policies [Abstract] | |
| NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES | 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES Basis of Presentation and Organization EOS Inc., a company in the developmental stage (the “Company”), was incorporated on April 3, 2015 in the State of Nevada. The Company has conducted limited business operations and had no revenues from operations since its inception. The Company‘s business plan is to market and distribute skin care products, including masks and serums. The Company’s year-end is December 31. Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern. For the period ended December 31, 2015, Company had limited operations. As of December 31, 2015, the Company has not emerged from the development stage. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from a loan commitment of $200,000 from Yu Cheng Yang, our President and sole director, which commitment is for 12 months, and all amounts lent by Mr. Yang pursuant to that commitment shall not accrue interest and shall be payable on demand; provided however, such command will not be made prior to the expiration of that 12 month period after the date of that commitment, which date is October 7, 2015. The financial statements of the Company did not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the accompanying financial statements, the Company has incurred an accumulated deficit of $149,991 for the period from inception (April 3, 2015) to December 31, 2015. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its planned business. The Company plans to seek additional funds through private placements of our securities and/or capital contributions and loans by Yu Cheng Yang, our President and sole director. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements included in the registration statement of which this prospectus is a part do not include any adjustments that might occur from this uncertainty. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less. Net Income (loss) per Share Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At December 31, 2015, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented. Income Taxes The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow. |
| DUE TO RELATED PARTIES | 9 Months Ended |
| Dec. 31, 2015 | |
| Related Party Transactions [Abstract] | |
| DUE TO RELATED PARTIES | 2. DUE TO RELATED PARTIES The Company has advanced funds from its officer and shareholder for working capital purposes. As of December 31, 2015, there were $150,000 advances outstanding. The Company has agreed that the outstanding balances bear 0% interest rate and are due upon demand after 30 days written notice by the officer and shareholder. |
| INCOME TAXES | 9 Months Ended |
| Dec. 31, 2015 | |
| Income Tax Disclosure [Abstract] | |
| INCOME TAXES | 3. INCOME TAXES The Company has not yet realized income as of the date of this report, and no provision for income taxes has been made. At December 31, 2015, there were no deferred tax assets or liabilities. |
| STOCKHOLDERS' DEFICIT | 9 Months Ended |
| Dec. 31, 2015 | |
| Equity [Abstract] | |
| STOCKHOLDERS' DEFICIT | 4. STOCKHOLDERS’ EQUITY From April 3, 2015 to December 31, 2015, the Company has issued 54,122,997 common stock shares at par value in a total amount of $54,123 from its shareholders. |
| SUBSEQUENT EVENTS | 9 Months Ended |
| Dec. 31, 2015 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | 5. SUBSEQUENT EVENTS On February 24, 2016, the Company has issued 10,000,000 shares of its $0.001 par value common stock shares at a purchase price of $0.01 per share in a total amount of $100,000 from fifteen shareholders. The Company evaluated all events or transactions that occurred after December 31, 2015 up through the date the Company issued these financial statements. |
| NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Policies) | 9 Months Ended |
| Dec. 31, 2015 | |
| Nature Of Operations And Summary Of Accounting Policies [Abstract] | |
| Basis of Presentation | Basis of Presentation and Organization EOS Inc., a company in the developmental stage (the “Company”), was incorporated on April 3, 2015 in the State of Nevada. The Company has conducted limited business operations and had no revenues from operations since its inception. The Company‘s business plan is to market and distribute skin care products, including masks and serums. The Company’s year-end is December 31. |
| Going Concern | Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern. For the period ended December 31, 2015, Company had limited operations. As of December 31, 2015, the Company has not emerged from the development stage. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from a loan commitment of $200,000 from Yu Cheng Yang, our President and sole director, which commitment is for 12 months, and all amounts lent by Mr. Yang pursuant to that commitment shall not accrue interest and shall be payable on demand; provided however, such command will not be made prior to the expiration of that 12 month period after the date of that commitment, which date is October 7, 2015. The financial statements of the Company did not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the accompanying financial statements, the Company has incurred an accumulated deficit of $149,991 for the period from inception (April 3, 2015) to December 31, 2015. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its planned business. The Company plans to seek additional funds through private placements of our securities and/or capital contributions and loans by Yu Cheng Yang, our President and sole director. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements included in the registration statement of which this prospectus is a part do not include any adjustments that might occur from this uncertainty. |
| Use of Estimates | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. |
| Cash and cash equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less. |
| Net Income (loss) per Share | Net Income (loss) per Share Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At December 31, 2015, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented. |
| Income Taxes | Income Taxes The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized. |
| Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow. |
| NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) | 9 Months Ended |
| Dec. 31, 2015USD ($) | |
| Nature Of Operations And Summary Of Accounting Policies [Roll Forward] | |
| Accumulated deficit | $ (149,991) |
| Yu Cheng Yang | |
| Nature Of Operations And Summary Of Accounting Policies [Roll Forward] | |
| Additional Funding From Loan Commitment | $ 200,000 |
| DUE TO RELATED PARTIES (Detail Textuals) | 9 Months Ended |
| Dec. 31, 2015USD ($) | |
| Related Party Transactions [Abstract] | |
| Advances outstanding of officer and shareholder | $ 150,000 |
| Interest rate of outstanding balances | 0.00% |
| Due of written notice by officer and shareholder | 30 days |
| STOCKHOLDERS' DEFICIT (Detail Textuals) | 9 Months Ended |
| Dec. 31, 2015USD ($)shares | |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |
| Common stock issuance | $ 54,123 |
| Common Stock | |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |
| Common stock issuance | $ 54,123 |
| Common stock issuance (in shares) | shares | 54,122,997 |
| SUBSEQUENT EVENTS (Detail Textuals) | 1 Months Ended | 9 Months Ended |
| Feb. 24, 2016USD ($)Shareholder$ / sharesshares | Dec. 31, 2015USD ($)$ / sharesshares | |
| Subsequent Event [Line Items] | ||
| Common stock shares issued | shares | 54,122,997 | |
| Common stock, par value (in dollars per share) | $ 0.001 | |
| Value for common stock | $ | $ 54,123 | |
| Subsequent Event | Shareholders | ||
| Subsequent Event [Line Items] | ||
| Common stock shares issued | shares | 10,000,000 | |
| Common stock, par value (in dollars per share) | $ 0.001 | |
| Shares issued, price per share | $ 0.01 | |
| Number of shareholders | Shareholder | 15 | |
| Value for common stock | $ | $ 100,000 |
